LCIP
LLY icon

Life Cycle Investment Partners’s Eli Lilly LLY Stock Holding History

Life Cycle Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150M Sell
125,054
-14,529
-10% -$14.8M 0.7% 34
2026
Q1 		$128M Buy
139,583
+48,441
+53% +$49.1M 0.82% 32
2025
Q4 		$97.9M Buy
+91,142
New +$87.1M 0.69% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Life Cycle Investment Partners's LLY Position: Q2 2026 in Review

Life Cycle Investment Partners reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $14.8M and leaving 125,054 shares worth $150M. The position accounts for 0.7% of the portfolio, ranked #34.

Life Cycle Investment Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 3,987 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Life Cycle Investment Partners held 125,054 shares of Eli Lilly worth $150M as of Q2 2026.
  • Life Cycle Investment Partners sold 14,529 Eli Lilly shares in Q2 2026, an estimated $14.8M.
  • Eli Lilly made up 0.7% of Life Cycle Investment Partners's portfolio in Q2 2026, its #34 holding.
  • Life Cycle Investment Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 3,987 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Life Cycle Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.